EMPLOYMENT AGREEMENTEmployment Agreement • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”), effective as of December 7, 2012 (the “Effective Date”), supercedes and replaces the Amended and Restated Employment Agreement dated January 15, 2008 (the “Prior Agreement”) by and between SCYNEXIS, Inc., a Delaware corporation (“Employer” or “Company”) and Dr. Yves J. Ribeill (“Employee”). Once this Agreement is in effect, the Prior Agreement shall have no further force or effect.
SCYNEXIS, INC. FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 20th, 2013 Company Industry Jurisdiction
ContractAgreement for the Assignment of Patents and Know How • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledDecember 20th, 2013 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
LICENSE AGREEMENTLicense Agreement • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledDecember 20th, 2013 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is made and entered into as of August 7th, 2012 (the “Effective Date”) by and between SCYNEXIS, INC., a Delaware corporation having its principal place of business at 3501C Tricenter Boulevard, Durham, NC 27713 USA (“Licensor”), and Dechra Ltd of Dechra House, Jamage Industrial Estate, Talke Pits, Stoke-on-Trent, ST7 1XW, United Kingdom (“Licensee”). Licensor and Licensee are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AMENDMENT 1 TO THE EXCLUSIVE WORLD-WIDE LICENSE AGREEMENT ENTERED INTO BY AND BETWEEN SCYNEXIS Inc and AVENTIS PHARMA S.A. ON MAY THE 10th, 2005Exclusive World-Wide License Agreement • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2013 Company IndustrySCYNEXIS, Inc., a company incorporated under the laws of the state of Delaware, whose principal office is at 3501 C Tricenter Boulevard, Durham, North Carolina, 27713 USA (“Scynexis”);
INDUSTRIAL BUILDING LEASE BETWEEN DURHAM RESEARCH TRI-CENTER, LLC, AS LANDLORD AND SCYNEXIS, INC., AS TENANT RESEARCH TRI-CENTER NORTH I DURHAM, NORTH CAROLINAIndustrial Building Lease • December 20th, 2013 • Scynexis Inc • Pharmaceutical preparations
Contract Type FiledDecember 20th, 2013 Company IndustryThis Industrial Building Lease Agreement (the “Lease”) is made and entered into as of the 13th day of July, 2007 to be effective as of July 1, 2007, between DURHAM RESEARCH TRICENTER, LLC, a Delaware limited liability company (“Landlord”), and SCYNEXIS, INC., a Delaware corporation (“Tenant”).